Filter posts

New Study: 340B Entities Not Using the Program as Intended

A new analysis released by Avalere Health and funded by the Alliance for Integrity and …

The Convergence of BioPharma and Digital Medicine

Our newfound capability of digitizing the medical essence of human beings with biosensors, imaging, sequencing …

Time: How to Breathe New Life Into America's Health-Care System

Last week, Rep. Fred Upton (R-MI) published an op-ed – How to Breathe New Life Into America’s …

Out of Africa: Biomedical Innovation and Expertise

Scientific research holds the key to unlocking creative and effective solutions for alleviating the burden …

John Lechleiter Forbes Op-Ed: Debunking the Five Big Myths About 'Big Pharma'

This week, Eli Lilly and Company President, Chairman and CEO John Lechleiter refutes five big …

More Than 90 Patient Organizations Urge Congress to Protect Patients and Innovation

Today, the Epilepsy Foundation and a diverse group of more than 90 advocacy organizations submitted …

BIO Applauds Energy and Commerce Health Subcommittee for Approving 21st Century Cures Act

Today, the Biotechnology Industry Organization (BIO) praises the Energy and Commerce Health Subcommittee for approving …

TSC Global Awareness Day

On May 15, the Tuberous Sclerosis Alliance (TS Alliance) will join tuberous sclerosis complex (TSC) …

Jim Greenwood in New York Times: Specialty Tiers Limit Patient Access

Today, the New York Times published a letter from Jim Greenwood, BIO’s President and CEO. …

Tick Size Pilot Program: A Few Pennies Make a Big Difference

Earlier this week, the Securities and Exchange Commission (SEC) approved a tick size pilot program …